Chartwell’s Biopharmaceuticals practice worked with clinical stage, precision medicine leader, Frontier Medicines, to recruit Gerardo Ubaghs as Chief Financial Officer. This appointment follows our prior work recruiting Frontier’s Chief Medical Officer, Andrew Krivoshik, MD, PhD, and the Company’s Senior Vice President and Head of Oncology and Inflammatory Disease Research, Lata Jayaraman, PhD. Mr. Ubaghs is…
Month: July 2024
Chartwell Partners is pleased to have worked with our long-standing client, Akebia Therapeutics, to recruit Mr. Ostrowski as Chief Financial Officer and Chief Business Officer. Mr. Ostrowski is an important addition to Akebia’s leadership team as the Company executes its US launch of Vafeso® for the treatment of anemia due to chronic kidney disease in…